Bloomberg News

SymBio Pharmaceuticals Sets IPO Price at 560 Yen per Share

October 11, 2011

Oct. 11 (Bloomberg) -- SymBio Pharmaceuticals Ltd. will sell shares for 560 yen each in an initial public offering, according to a statement today on the company’s website.

The Tokyo-based drug developer will list its shares on the Osaka Securities Exchange’s Jasdaq Growth market on Oct. 20.

To contact the editor responsible for this story: Taku Kato at tkato6@bloomberg.net


China's Killer Profits
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus